Clincosm LogoSign in Get a demo

Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)

Sponsor
Mayo Clinic (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01569373
Collaborator
(none)
0
Enrollment
1
Location
67
Duration (Months)
0
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Samples of blood and urine will be analyzed for biomarkers to check their predictivity of Graft-versus-Host Disease (GVHD) outcomes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To determine if serum biomarkers of inflammation correlate with onset and severity of acute GVHD, particularly GVHD of the gut.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD).
    Study Start Date :
    Mar 1, 2012
    Anticipated Primary Completion Date :
    Oct 1, 2017
    Anticipated Study Completion Date :
    Oct 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    Post allogeneic SCT patients

    Patients who have undergone an allogeneic stem cell transplant.

    Outcome Measures

    Primary Outcome Measures

    1. Diagnosis of severe acute GVHD [2 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • 18 years old or older patients

    • Undergoing allogeneic stem cell transplant

    Exclusion Criteria:

    None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: Mark Litzow, MD, Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mark R. Litzow, MD, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT01569373
    Other Study ID Numbers:
    • 12-001493
    First Posted:
    Apr 3, 2012
    Last Update Posted:
    Oct 19, 2017
    Last Verified:
    Oct 1, 2017
    Keywords provided by Mark R. Litzow, MD, Mayo Clinic
    Allogeneic stem cell transplant
    Graft versus Host Disease
    GVHD
    Additional relevant MeSH terms:
    Graft vs Host Disease

    Study Results

    No Results Posted as of Oct 19, 2017